Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review

Angel C Rebollo-Aguirre1, Carlos Ramos-Font, Román Villegas Portero

  • 1Department of Nuclear Medicine, University Hospital Virgen de las Nieves, Granada, Spain. angelc.rebollo.sspa@juntadeandalucia.es

Abstract